Gerald Mattys | CEO & Director |
Brent Moen | CFO |
William Inglis | Piper Jaffray Companies |
Christopher Pasquale | Guggenheim Securities |
Anna Nussbaum | William Blair & Company |
David Rescott | Canaccord Genuity Limited |
Suraj Kalia | Northland Capital Markets |
Lalishwar Ramgopal | Sidoti & Company |
Please standby. Good afternoon, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2018 Earnings Conference Call for Tactile Medical. [Operator Instructions]. Please note that this conference call is being recorded, and that the recording will be available on the company's website for replay shortly.
Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the Risk Factors section of our most recent annual report on Form 10-K filed today with the Securities and Exchange Commission as well as our most recent 10-Q filing.